Monday, October 05, 2015 6:10:32 AM
Good results in Pivotal P2B Clinical Trial potentially often result in FDA advanced Commercial approvals for medical therapies for unmet medical needs where often death within 6 to 12 months is the case with current ineffective therapies.
Pivotal P2B agreed Protocol always take the longest to get the FDA full agreement. Often 6 to 9 months with back and forth FDA discussions. In the several Pharmas that I track with Pivotal P2Bs, the exact situation is going on with lengthy delays. Shareholders become frustrated as Shorts attack the PPS.
It is the time for Investors to do deeper DD, and for those that do IMO, it is a great opportunity to add more shares on the cheap.
$ONCS Combo Pivotal P2B with MRK's Keytruda has been underway since July/Aug and apparently UCSF has undertake total sponsorship for the 41 person Clinical Trial.
https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM